Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Mar;4(2):236–240. doi: 10.1128/cdli.4.2.236-240.1997

Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies--an interesting association.

M Kalenian 1, B Zweiman 1
PMCID: PMC170510  PMID: 9067664

Abstract

We report an interesting association of inflammatory myopathy, characterized pathologically as dermatomyositis, with bronchiolitis obliterans/organizing pneumonia and anti-histidyl-tRNA synthetase (Jo-1) antibody. The relations of different types of pulmonary involvement to inflammatory myopathy and antisynthetase antibodies are discussed.

Full Text

The Full Text of this article is available as a PDF (241.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arsura E. L., Greenberg A. S. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum. 1988 Aug;18(1):29–37. doi: 10.1016/0049-0172(88)90032-7. [DOI] [PubMed] [Google Scholar]
  2. Bernstein R. M., Morgan S. H., Chapman J., Bunn C. C., Mathews M. B., Turner-Warwick M., Hughes G. R. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984 Jul 21;289(6438):151–152. doi: 10.1136/bmj.289.6438.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boyd A. S., Neldner K. H. Therapeutic options in dermatomyositis/polymyositis. Int J Dermatol. 1994 Apr;33(4):240–250. doi: 10.1111/j.1365-4362.1994.tb01034.x. [DOI] [PubMed] [Google Scholar]
  4. Falga Tirado C., Valero Rovira S., Cucurull Canosa E., Pérez Pemán P., Ordi Ros J. Bronquiolitis obliterante con neumonía organizativa recidivante como primera manifestación de una polimiositis. An Med Interna. 1995 Oct;12(10):498–500. [PubMed] [Google Scholar]
  5. Fudman E. J., Schnitzer T. J. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis. Semin Arthritis Rheum. 1986 May;15(4):255–260. doi: 10.1016/0049-0172(86)90021-1. [DOI] [PubMed] [Google Scholar]
  6. Hsue Y. T., Paulus H. E., Coulson W. F. Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival. J Rheumatol. 1993 May;20(5):877–879. [PubMed] [Google Scholar]
  7. Imokawa S., Sato A., Iwata M., Suda T., Shichi I., Yasuda K., Genma H., Okano A., Hayakawa H., Chida K. [A case of bronchiolitis obliterans organizing pneumonia with positive anti Jo-1 antibody preceding polymyositis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1992 May;30(5):914–919. [PubMed] [Google Scholar]
  8. Iwata M., Sato A., Kitazawa H., Chida K., Hayakawa H., Akiyama J., Kishimoto H., Okano A., Tanguchi M. [Clinicopathologic study of various lung diseases with bronchiolitis obliterans organizing pneumonia (BOOP) pattern in open lung biopsy]. Nihon Kyobu Shikkan Gakkai Zasshi. 1991 Dec;29(12):1582–1590. [PubMed] [Google Scholar]
  9. Kalovidouris A. E. Mechanisms of inflammation and histopathology in inflammatory myopathy. Rheum Dis Clin North Am. 1994 Nov;20(4):881–897. [PubMed] [Google Scholar]
  10. Lakhanpal S., Lie J. T., Conn D. L., Martin W. J., 2nd Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis. 1987 Jan;46(1):23–29. doi: 10.1136/ard.46.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Love L. A., Leff R. L., Fraser D. D., Targoff I. N., Dalakas M., Plotz P. H., Miller F. W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991 Nov;70(6):360–374. doi: 10.1097/00005792-199111000-00002. [DOI] [PubMed] [Google Scholar]
  12. Moxley R. T., 3rd Evaluation of neuromuscular function in inflammatory myopathy. Rheum Dis Clin North Am. 1994 Nov;20(4):827–843. [PubMed] [Google Scholar]
  13. Nishikai M., Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980 Aug;23(8):881–888. doi: 10.1002/art.1780230802. [DOI] [PubMed] [Google Scholar]
  14. Pachman L. M. Juvenile dermatomyositis (JDMS): new clues to diagnosis and pathogenesis. Clin Exp Rheumatol. 1994 Sep-Oct;12 (Suppl 10):S69–S73. [PubMed] [Google Scholar]
  15. Reichlin M., Arnett F. C., Jr Multiplicity of antibodies in myositis sera. Arthritis Rheum. 1984 Oct;27(10):1150–1156. doi: 10.1002/art.1780271011. [DOI] [PubMed] [Google Scholar]
  16. Schumacher H. R., Schimmer B., Gordon G. V., Bookspan M. A., Brogadir S., Dorwart B. B. Articular manifestations of polymyositis and dermatomyositis. Am J Med. 1979 Aug;67(2):287–292. doi: 10.1016/0002-9343(79)90404-2. [DOI] [PubMed] [Google Scholar]
  17. Schwarz M. I. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging. 1992 Mar;7(2):46–54. doi: 10.1097/00005382-199203000-00006. [DOI] [PubMed] [Google Scholar]
  18. Schwarz M. I., Sutarik J. M., Nick J. A., Leff J. A., Emlen J. W., Tuder R. M. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995 Jun;151(6):2037–2040. doi: 10.1164/ajrccm.151.6.7767555. [DOI] [PubMed] [Google Scholar]
  19. Targoff I. N., Arnett F. C. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase). Am J Med. 1990 Mar;88(3):241–251. doi: 10.1016/0002-9343(90)90149-8. [DOI] [PubMed] [Google Scholar]
  20. Targoff I. N. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol. 1993 Jan;100(1):116S–123S. doi: 10.1111/1523-1747.ep12356607. [DOI] [PubMed] [Google Scholar]
  21. Targoff I. N., Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol. 1987 May 1;138(9):2874–2882. [PubMed] [Google Scholar]
  22. Tazelaar H. D., Viggiano R. W., Pickersgill J., Colby T. V. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis. 1990 Mar;141(3):727–733. doi: 10.1164/ajrccm/141.3.727. [DOI] [PubMed] [Google Scholar]
  23. Yoshida S., Akizuki M., Mimori T., Yamagata H., Inada S., Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983 May;26(5):604–611. doi: 10.1002/art.1780260505. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES